Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Diminished type I collagen synthesis and reduced alpha 1(I) collagen messenger RNA in cultured fibroblasts from patients with dominantly inherited (type I) osteogenesis imperfecta.
D W Rowe, … , M Poirier, S Schlesinger
D W Rowe, … , M Poirier, S Schlesinger
Published August 1, 1985
Citation Information: J Clin Invest. 1985;76(2):604-611. https://doi.org/10.1172/JCI112012.
View: Text | PDF
Research Article

Diminished type I collagen synthesis and reduced alpha 1(I) collagen messenger RNA in cultured fibroblasts from patients with dominantly inherited (type I) osteogenesis imperfecta.

  • Text
  • PDF
Abstract

Type I osteogenesis imperfecta (OI) is characterized clinically by a moderate fracture frequency with minimal bone deformity and dominant inheritance. Previous studies of the collagenous proteins synthesized by dermal fibroblasts obtained from unrelated patients with this form of OI suggested that the biochemical basis of the disease was reduced production of type I collagen. This study was designed to determine if this biochemical finding segregated with the disease within an individual family. Dermal fibroblast strains were established from three generations of a family having the typical features of type I OI. Analysis of the collagenous proteins made in culture revealed an elevated alpha 1(III) to alpha 1(I) collagen type ratio and an elevated alpha 1(I) to alpha 2(I) collagen chain ratio. The procollagen that accumulated in the medium reflected these ratios to the same degree. Total collagen synthesis was significantly reduced in affected family members. Therefore, the most striking abnormality in affected members was a 50-75% reduction of type I collagen production. Furthermore, the ratio of the alpha 1(I)/alpha 2(I) collagen messenger RNA (mRNA), measured by dot hybridization, was one-half of the value of uninvolved family members and unrelated controls. Since the reduction in the production of type I collagen and the altered alpha 1(I)/alpha 2(I) mRNA ratio clearly segregated with affected individuals within this family, these biochemical measurements may be a useful genetic marker for type I OI.

Authors

D W Rowe, J R Shapiro, M Poirier, S Schlesinger

×

Total citations by year

Year: 2021 2018 2016 2013 2012 2011 2009 2008 2007 2006 2004 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 1986 1985 1984 Total
Citations: 1 2 3 1 3 1 4 2 3 2 2 2 1 3 1 3 2 4 3 4 2 5 4 6 5 7 1 5 1 1 84
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (84)

Title and authors Publication Year
Restoration of Osteogenesis by CRISPR/Cas9 Genome Editing of the Mutated COL1A1 Gene in Osteogenesis Imperfecta
H Jung, YA Rim, N Park, Y Nam, JH Ju
Journal of Clinical Medicine 2021
The incidence of incisional hernia after aortic aneurysm is not higher than after benign colorectal interventions: A retrospective control-matched cohort study
A Wiegering, D Liebetrau, S Menzel, C Bühler, R Kellersmann, UA Dietz
Gefässchirurgie 2018
Die Inzidenz von Narbenhernien nach Aortenaneurysma ist nicht höher als nach benignen kolorektalen Eingriffen: Eine retrospektive Matched-control-Kohortenstudie
A Wiegering, D Liebetrau, S Menzel, C Bühler, R Kellersmann, UA Dietz
Gefässchirurgie 2018
Variations of SOST mRNA expression in human bone are associated with DNA polymorphism and DNA methylation in the SOST gene
L Lhaneche, JD Hald, A Domingues, D Hannouche, M Delepine, D Zelenika, A Boland, A Ostertag, M Cohen-Solal, BL Langdahl, T Harsløf, MC Vernejoul, V Geoffroy, F Jehan
Bone 2016
The genetics and pathogenesis of thoracic aortic aneurysm disorder and dissections: The genetics of TAADs
L Zhang, HH Wang
Clinical Genetics 2016
Collagen Accumulation in Osteosarcoma Cells lacking GLT25D1 Collagen Galactosyltransferase
S Baumann, T Hennet
The Journal of biological chemistry 2016
Genetics of Bone Biology and Skeletal Disease
CS Kovacs
Genetics of Bone Biology and Skeletal Disease 2013
A scoring system for the assessment of clinical severity in osteogenesis imperfecta
MS Aglan, L Hosny, R El-Houssini, S Abdelhadi, F Salem, RA ElBanna, SA Awad, ME Zaki, SA Temtamy
Journal of Children s Orthopaedics 2012
Methods in Enzymology
JD Stone, AS Chervin, DH Aggen, DM Kranz
Protein Engineering for Therapeutics Part B 2012
Incisional hernia recurrence through genomic profiling: a pilot study
R Calaluce, JW Davis, SL Bachman, MM Gubin, JA Brown, JD Magee, TS Loy, BJ Ramshaw, U Atasoy
Hernia 2012
Orthognathic Surgery Considerations for Patients With Undiagnosed Type I Osteogenesis Imperfecta
H Tashima, K Wattanawong, CT Ho, E Wen-Ching-Ko, A Nguyen, LJ Lo
Journal of Oral and Maxillofacial Surgery 2011
Severe osteogenesis imperfecta in cyclophilin B-deficient mice
JW Choi, SL Sutor, L Lindquist, GL Evans, BJ Madden, HR 3rd, TE Hefferan, MJ Yaszemski, RJ Bram
PLoS genetics 2009
Osteogenesis Imperfecta and Orthognathic Surgery: Case Report and Literature Review
JM López-Arcas, M Chamorro, JL Castillo, JL Cebrián, E Palacios, M Burgueño
Journal of Oral and Maxillofacial Surgery 2009
Severe Osteogenesis Imperfecta in Cyclophilin B–Deficient Mice
JW Choi, SL Sutor, L Lindquist, GL Evans, BJ Madden, HR Bergen, TE Hefferan, MJ Yaszemski, RJ Bram, PH Byers
PLoS genetics 2009
Osteoporosi e malattie metaboliche dell’osso
CV Albanese, R Passariello
2009
Principles of Bone Biology
CJ Rosen, T Niu
Principles of Bone Biology 2008
Collagen
P Fratzl
2008
Studies of Otic Capsule Morphology and Gene Expression in the Mov13 Mouse – An Animal Model of Type I Osteogenesis Imperfecta
KM Stankovic, AG Kristiansen, A Bizaki, M Lister, JC Adams, MJ McKenna
Audiology and Neurotology 2007
Pathologies génétiques des collagènes et conséquences sur le développement cranio-facial
AS Kamoun-Goldrat
L'Orthodontie Française 2007
Abnormal Primary Tissue Collagen Composition in the Skin of Recurrent Incisional Hernia Patients
B White, C Osier, N Gletsu, L Jeansonne, M Baghai, M Sherman, CD Smith, B Ramshaw, E Lin
The American surgeon 2007
Orthodontic Treatment and Orthognathic Surgery for Patients with Osteogenesis Imperfecta
JK Hartsfield, WF Hohlt, WE Roberts
Seminars in Orthodontics 2006
Laparoscopic incisional hernia repair: a review of the literature
LR Rudmik, C Schieman, E Dixon, E Debru
Hernia 2006
Reduced type I collagen utilization: A pathogenic mechanism in COL5A1 haplo-insufficient Ehlers-Danlos syndrome
RJ Wenstrup, JB Florer, WG Cole, MC Willing, DE Birk
Journal of Cellular Biochemistry 2004
Gene therapy approaches for osteogenesis imperfecta
C Niyibizi, S Wang, Z Mi, PD Robbins
Gene Therapy 2004
Impaired balance of type I and type III procollagen mRNA in cultured fibroblasts of patients with incisional hernia
Z Si, R Bhardwaj, R Rosch, PR Merten, B Klosterhalfen, U Klinge
Surgery 2002
Mechanisms and Metabolic Characteristics of Hernia Formation:
SL Goldstein
Problems in General Surgery 2002
Transfer of pro?2(I) cDNA into cells of a murine model of human Osteogenesis Imperfecta restores synthesis of type I collagen comprised of ?1(I) and ?2(I) heterotrimers in vitro and in vivo
C Niyibizi, P Smith, Z Mi, CL Phillips, P Robbins
Journal of Cellular Biochemistry 2001
Tracking Col1a1 RNA in Osteogenesis Imperfecta: Splice-Defective Transcripts Initiate Transport from the Gene but Are Retained within the Sc35 Domain
C Johnson, D Primorac, M McKinstry, J McNeil, D Rowe, JB Lawrence
The Journal of Cell Biology 2000
Osteogenesis Imperfecta
F Antoniazzi, M Mottes, P Fraschini, PC Brunelli, L Tat??
Paediatric Drugs 2000
Tracking COL1A1 RNA in osteogenesis imperfecta. splice-defective transcripts initiate transport from the gene but are retained within the SC35 domain
C Johnson, D Primorac, M McKinstry, J McNeil, D Rowe, JB Lawrence
The Journal of Cell Biology 2000
Co-existence of osteogenesis imperfecta and hyperparathyroidism
T Zimmermann-Belsing, AM Lund, L Christensen, U Feldt-Rasmussen
Journal of Endocrinological Investigation 1999
Advances in Organ Biology
AJ Liedtke
Advances in Organ Biology 1998
Metabolic Bone Disease and Clinically Related Disorders
FR Singer, SM Krane
Metabolic Bone Disease and Clinically Related Disorders 1998
1,25-Dihydroxyvitamin D3 inhibition of Col1a1 promoter expression in calvariae from neonatal transgenic mice
A Bedalov, R Salvatori, M Dodig, B Kapural, D Pavlin, BE Kream, SH Clark, CO Woody, DW Rowe, AC Lichtler
Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression 1998
Osteoporosis
DL Glaser, FS Kaplan
Spine 1997
STRATEGIES AND OUTCOMES OF PRENATAL DIAGNOSIS FOR OSTEOGENESIS IMPERFECTA: A REVIEW OF BIOCHEMICAL AND MOLECULAR STUDIES COMPLETED IN 129 PREGNANCIES
M Pepin, M Atkinson, BJ Starman, PH Byers
Prenatal Diagnosis 1997
Nuclear retention of COL1A1 messenger RNA identifies null alleles causing mild osteogenesis imperfecta
DA Redford-Badwal, ML Stover, M Valli, MB McKinstry, DW Rowe
Journal of Clinical Investigation 1996
Collagen peptides in osteogenesis imperfecta, idiopathic juvenile osteoporosis and Ehlers–Danlos syndrome
K Prószyńska, E Wieczorek, M Olszaniecka, RS Lorenc
Acta Paediatrica 1996
Premature chain termination is a unifying mechanism for COL1A1 null alleles in osteogenesis imperfecta type I cell strains
MC Willing, SP Deschenes, RL Slayton, EJ Roberts
The American Journal of Human Genetics 1996
Growth hormone treatment in osteogenesis imperfecta with quantitative defect of type I collagen synthesis
F Antoniazzi, F Bertoldo, M Mottes, M Valli, S Sirpresi, G Zamboni, R Valentini, L Tatò
The Journal of Pediatrics 1996
The strength of a calcified tissue depends in part on the molecular structure and organization of its constituent mineral crystals in their organic matrix
WJ Landis
Bone 1995
Tomographic Imaging of Collagen-Mineral Interaction: Implications for Osteogenesis Imperfecta
WJ Landis
Connective Tissue Research 1995
Absence of mutations in the promoter of the COL1A1 gene of type I collagen in patients with osteogenesis imperfecta type I
MC Willing, RL Slayton, SH Pitts, SP Deschenes
Journal of medical genetics 1995
Upstream regulatory elements necessary for expression of the rat COL1A1 promoter in transgenic mice
Z Bogdanovic, A Bedalov, PH Krebsbach, D Pavlin, CO Woody, SH Clark, HF Thomas, DW Rowe, BE Kream, AC Lichtler
Journal of Bone and Mineral Research 1994
Osteogenesis imperfecta: Comparison of molecular defects with bone histological changes
R Sztrolovics, FH Glorieux, R Travers, M der Rest, PJ Roughley
Bone 1994
Osteogenesis imperfecta type I: molecular heterogeneity for COL1A1 null alleles of type I collagen
MC Willing, SP Deschenes, DA Scott, PH Byers, RL Slayton, SH Pitts, H Arikat, EJ Roberts
The American Journal of Human Genetics 1994
Reduced serum levels of car☐y-terminal propeptide of human type I procollagen in a family with type I-A osteogenesis imperfecta
S Minisola, AL Piccioni, R Rosso, E Romagnoli, MT Pacitti, L Scarnecchia, G Mazzuoli
Metabolism 1994
Serum concentrations of procollagen I C-terminal propeptide, osteocalcin and insulin-like growth factor-I in patients with non-lethal osteogenesis irnperfecta
RE Brenner, B Schiller, U Vetter, J Ittner, WM Teller
Acta Paediatrica 1993
Mutations in the COL1A2 gene of type I collagen that result in nonlethal forms of osteogenesis imperfecta
RJ Wenstrup, LW Lever, CL Phillips, LD Quarles
American Journal of Medical Genetics 1993
Molecular nosology of heritable disorders of connective tissue
P Beighton, AD Paepe, JG Hall, DW Hollister, FM Pope, RE Pyeritz, B Steinmann, P Tsipouras
American Journal of Medical Genetics 1992
Type II collagen defect in two sibs with the Goldblatt syndrome, a chondrodysplasia with dentinogenesis imperfecta, and joint laxity
J Bonaventure, R Stanescu, V Stanescu, JC Allain, MP Muriel, D Ginisty, P Maroteaux
American Journal of Medical Genetics 1992
Osteogenesis imperfecta type I is commonly due to a COL1A1 null allele of type I collagen
MC Willing, CJ Pruchno, M Atkinson, PH Byers
The American Journal of Human Genetics 1992
Mutations in Collagen Genes as a Cause of Connective-Tissue Diseases
JS Flier, LH Underhill, DJ Prockop
New England Journal of Medicine 1992
Lipocyte activation and hepatic fibrosis
DM Bissell
Gastroenterology 1992
Cysteine in the triple helical domain of the pro?2(I) chain of type-I collagen in nonlethal forms of osteogenesis imperfecta
DH Cohn, PH Byers
Human Genetics 1991
A de novo G to T transversion in a pro-alpha 1 (I) collagen gene for a moderate case of osteogenesis imperfecta. Substitution of cysteine for glycine 178 in the triple helical domain
M Valli, M Mottes, R Tenni, A Sangalli, MG Lira, A Rossi, F Antoniazzi, G Cetta, PF Pignatti
The Journal of biological chemistry 1991
The effects of different cysteine for glycine substitutions within alpha 2(I) chains. Evidence of distinct structural domains within the type I collagen triple helix
RJ Wenstrup, AW Shrago-Howe, LW Lever, CL Phillips, PH Byers, DH Cohn
The Journal of biological chemistry 1991
Phenotypic variability and abnormal type I collagen unstable at body temperature in a family with mild dominant osteogenesis imperfecta
R Tenni, P Biglino, K Dyne, A Rossi, M Filocamo, F Pendola, P Brunelli, P Buttitta, C Borrone, G Cetta
Journal of Inherited Metabolic Disease 1991
Frameshift mutation near the 3' end of the COL1A1 gene of type I collagen predicts an elongated Pro alpha 1(I) chain and results in osteogenesis imperfecta type I
MC Willing, DH Cohn, PH Byers
Journal of Clinical Investigation 1990
Altered collagen metabolism in osteogenesis imperfecta fibroblasts: a study on 33 patients with diverse forms
RE Brenner, U Vetter, A Nerlich, O Wörsdorfer, WM Teller, PK Müller
European Journal of Clinical Investigation 1990
Moderately Severe Osteogenesis Imperfecta: Biochemical Studies Showing Variable Defect Localization in the Triple-Helical Domain of Type I Collagen
M Valli, R Tenni, G Cetta
Matrix 1990
Studies of type I collagen in osteogenesis imperfecta
MJ Edwards, JM Graham
The Journal of Pediatrics 1990
Clinical Screening for Collagen Defects in Connective Tissue Diseases
DH Cohn, PH Byers
Clinics in Perinatology 1990
Segregation analysis of dominant osteogenesis imperfecta in Italy
M Mottes, L Cugola, N Cappello, PF Pignatti
Journal of medical genetics 1990
Osteoporosis and Familial Idiopathic Scoliosis: Association with an Abnormal Alpha 2(I) Collagen
JR Shapiro, VE Burn, SD Chipman, KP Velis, M Bansal
Connective Tissue Research 1989
Osteogenesis imperfecta: insufficient collagen synthesis in early childhood as evidenced by analysis of compact bone and fibroblast cultures
RE Brenner, U Vetter, A Nerlich, O Wörsdorfer, WM Teller, PK Müller
European Journal of Clinical Investigation 1989
Increased expression of the gene for the pro alpha 1(IV) chain of basement-membrane procollagen in cultured skin fibroblasts from two variants of osteogenesis imperfecta
T Pihlajaniemi, J McKeon, S Gay, R Gay, WJ de Wet, JC Myers, DJ Prockop
Biochemical Journal 1989
Single base pair alterations as the predominant category of mutation in type I osteogenesis imperfecta
AJ Brookes, B Sykes, E Solomon
Journal of medical genetics 1989
Detection of Mutations in Human Type I Collagen mRNA in Osteogenesis Imperfecta by Indirect RNase Protection
C Genovese, A Brufsky, J Shapiro, D Rowe
The Journal of biological chemistry 1989
Delayed Triple-Helix Formation of Abnormal Type I Collagen Is Corrected by Reduced Temperature
A Superti-Furga, PM Royce, FM Pistone, C Romano, B Steinmann
Annals of the New York Academy of Sciences 1988
Biochemical Heterogeneity of Type I Collagen Mutations in Osteogenesis Imperfecta
JF Bateman, D Chan, S Lamande, T Mascara, WG Cole
Annals of the New York Academy of Sciences 1988
Imperfect Collagenesis in Osteogenesis Imperfecta The Consequences of Cysteine-Glycine Substitutions upon Collagen Structure and Metabolism
B Steinmann, A Superti-Furga, PM Royce
Annals of the New York Academy of Sciences 1988
Ascorbic Acid Specifically Increases Type I and Type III Procollagen Messenger RNA Levels in Human Skin Fibroblasts
JC Geesin, D Darr, R Kaufman, S Murad, SR Pinnell
Journal of Investigative Dermatology 1988
9 Osteogenesis imperfecta
WG Cole
Baillière's Clinical Endocrinology and Metabolism 1988
Human Achondroplasia: A Multidisciplinary Approach
B Nicoletti, SE Kopits, E Ascani, VA McKusick, SC Dryburgh
1988
Arginine for glycine substitution in the triple-helical domain of the products of one alpha 2(I) collagen allele (COL1A2) produces the osteogenesis imperfecta type IV phenotype
RJ Wenstrup, DH Cohn, T Cohen, PH Byers
The Journal of biological chemistry 1988
Genetic disorders of collagen
P Tsipouras, F Ramirez
Journal of medical genetics 1987
Osteogenesis imperfecta type IV. Biochemical confirmation of genetic linkage to the pro alpha 2(I) gene of type I collagen
RJ Wenstrup, P Tsipouras, PH Byers
Journal of Clinical Investigation 1986
Developmental genetics
CJ Epstein
Experientia 1986
Collagen defects in lethal perinatal osteogenesis imperfecta
JF Bateman, D Chan, T Mascara, JG Rogers, WG Cole
Biochemical Journal 1986
Osteogenesis imperfecta type IV: evidence of abnormal triple helical structure of type I collagen
RJ Wenstrup, AG Hunter, PH Byers
Human Genetics 1986
Ehlers-Danlos syndrome type IV: cosegregation of the phenotype to a COL3A1 allele of type III procollagen
P Tsipouras, PH Byers, RC Schwartz, ML Chu, D Weil, G Pepe, SB Cassidy, F Ramirez
Human Genetics 1986
Genetic and Metabolic Disease in Pediatrics
L Pinsky, M Kaufman
Genetic and Metabolic Disease in Pediatrics 1985
Progress in Nucleic Acid Research and Molecular Biology
FS Collins, SM Weissman
Progress in nucleic acid research and molecular biology 1984

← Previous 1 2 3 4 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts